Kenvue Inc. Common Stock vs MobilEye Global Inc — how do they compare? Kenvue Inc. Common Stock trades at $17.71 (market cap $34.06B), while MobilEye Global Inc trades at $7.16 (market cap $6.00B). The key difference: Kenvue Inc. Common Stock is far larger — about 5.7× MobilEye Global Inc's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while MobilEye Global Inc pays none. Which is the better fit depends on your goals.
| KVUE | MBLY | |
|---|---|---|
Market Cap | $34.06B | $6.00B |
Volume | 23,267,228 | 7,007,849 |
Sector | Consumer Staples | Consumer Cyclical |
52-Week High | $19.83 | $15.42 |
52-Week Low | $14.11 | $6.56 |
Enterprise Value | $41.56B | $4.56B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 15 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Mobileye Global (MBLY) trades at $7.11, down 0.56% on the day, with a bearish technical outlook but mixed fundamental signals. The stock shows negative profitability with a net income margin of -201.49% for 2026, yet revenue grew to $2.0 billion. Recent earnings beats in Q1 and Q2 2026 contrast with a Q4 2025 miss, while analyst consensus is a 'Buy' with a $10.83 price target. News highlights ADAS momentum and a robotaxi strategy expansion, but the stock faces significant cash flow volatility.
The outlook for MBLY is cautious; while analyst optimism and revenue growth provide upside potential, persistent losses and bearish technicals pose risks. Investment opportunity hinges on execution of autonomous driving programs, but shareholders face volatility from negative earnings and high valuation multiples like EV/EBITDA of 32.34.
Trailing returns across standard periods
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →